Representative photographs of 3 subjects. (A-E) A 58-year-old woman with Fitzpatrick Type II skin who was treated with DKL23 in the right NLF and with Juvéderm Volift with lidocaine in the left NLF: (A) baseline, (B) 1 month posttreatment, (C) 3 months posttreatment, (D) 6 months posttreatment, (E) 9 months posttreatment. (F-J) A 55-year-old woman with Fitzpatrick Type II skin who was treated with DKL23 in the left NLF and with Juvéderm Volift with lidocaine in the right NLF: (F) baseline, (G) 1 month posttreatment, (H) 3 months posttreatment, (I) 6 months posttreatment, (J) 9 months posttreatment. (K-O) A 51-year-old woman with Fitzpatrick Type III skin who was treated with DKL23 in the right NLF and with Juvéderm Volift with lidocaine in the left NLF: (K) baseline, (L) 1 month posttreatment, (M) 3 months posttreatment, (N) 6 months posttreatment, (O) 9 months posttreatment. NLF, nasolabial fold.